We are live on ! Find out more
EIP

Easterly Investment Partners Portfolio holdings

AUM $1.97B
1-Year Est. Return 25.87%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+25.87%
3 Year Est. Return
+57.65%
5 Year Est. Return
+62.99%
10 Year Est. Return
AUM
$935M
AUM Growth
+$26.4M
Cap. Flow
-$50.8M
Cap. Flow %
-5.43%
Top 10 Hldgs %
20.16%
Holding
209
New
24
Increased
46
Reduced
78
Closed
16

Top Buys

Rank Stock Value
1
FMC icon
FMC
FMC
+$12.1M
2
IART icon
Integra LifeSciences
IART
+$9.46M
3
UL icon
Unilever
UL
+$8.06M
4
CVX icon
Chevron
CVX
+$7.62M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.44M

Sector Composition

Rank Sector Weight
1 Financials 20.21%
2 Healthcare 14.62%
3 Technology 14.15%
4 Energy 11.94%
5 Industrials 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATL icon
101
NCR Atleos
NATL
$3.45B
$2.01M 0.22%
+82,878
New +$1.9M
PCAR icon
102
PACCAR
PCAR
$64.6B
$1.99M 0.21%
20,388
AMLP icon
103
Alerian MLP ETF
AMLP
$13.6B
$1.98M 0.21%
46,619
AAP icon
104
Advance Auto Parts
AAP
$2.7B
$1.98M 0.21%
32,425
+26,068
+410% +$1.43M
OPTN
105
DELISTED
OptiNose
OPTN
$1.96M 0.21%
101,421
+17,605
+21% +$321K
EXE
106
Expand Energy Corp
EXE
$22B
$1.95M 0.21%
25,401
+346
+1% +$28.4K
HIG icon
107
Hartford Financial Services
HIG
$36.9B
$1.95M 0.21%
24,299
-92,839
-79% -$6.99M
PFE icon
108
Pfizer
PFE
$158B
$1.94M 0.21%
67,356
-338,645
-83% -$10.2M
CRI icon
109
Carter's
CRI
$1.12B
$1.94M 0.21%
25,849
-263
-1% -$18.3K
ZION icon
110
Zions Bancorporation
ZION
$10B
$1.93M 0.21%
43,940
-4,500
-9% -$163K
PNC icon
111
PNC Financial Services
PNC
$97.4B
$1.89M 0.2%
12,201
+8,000
+190% +$1.04M
FCF icon
112
First Commonwealth Financial
FCF
$2.15B
$1.88M 0.2%
121,822
PCRX icon
113
Pacira BioSciences
PCRX
$1.01B
$1.87M 0.2%
55,444
+17,594
+46% +$515K
KEY icon
114
KeyCorp
KEY
$23.3B
$1.85M 0.2%
128,781
-12,000
-9% -$142K
NOG icon
115
Northern Oil and Gas
NOG
$2.83B
$1.83M 0.2%
49,427
+4,760
+11% +$180K
VUG icon
116
Vanguard Morningstar Growth ETF
VUG
$226B
$1.79M 0.19%
34,536
IUSV icon
117
iShares Core S&P US Value ETF
IUSV
$27.7B
$1.73M 0.18%
+20,495
New +$1.6M
AAPL icon
118
Apple
AAPL
$4.85T
$1.61M 0.17%
8,372
NUE icon
119
Nucor
NUE
$58.9B
$1.57M 0.17%
9,001
GDXJ icon
120
VanEck Junior Gold Miners ETF
GDXJ
$9.32B
$1.54M 0.16%
40,692
COLL icon
121
Collegium Pharmaceutical
COLL
$741M
$1.53M 0.16%
49,651
MPLX icon
122
MPLX
MPLX
$60.7B
$1.47M 0.16%
40,001
VST icon
123
Vistra
VST
$49.8B
$1.46M 0.16%
37,856
-490
-1% -$17K
ACCO icon
124
Acco Brands
ACCO
$391M
$1.37M 0.15%
224,576
-141,284
-39% -$749K
IFF icon
125
International Flavors & Fragrances
IFF
$21.3B
$1.32M 0.14%
+16,331
New +$1.18M

Similar funds

Easterly Investment Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Easterly Investment Partners held 209 positions worth $935M, up 2.9% from $909M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Easterly Investment Partners withdrew a net $50.8M in Q4 2023, closing 16 positions and reducing 78 holdings. Its most notable exit was Dominion Energy, an estimated $9.76M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Easterly Investment Partners opened a new position in FMC worth $13.2M.

  • Easterly Investment Partners's largest Q4 2023 buy was FMC: 209,010 shares worth $13.2M.
  • Easterly Investment Partners added most to Integra LifeSciences in Q4 2023, an estimated $9.46M increase.
  • Easterly Investment Partners's biggest Q4 2023 reduction was Pfizer, cutting an estimated $10.2M.
  • Easterly Investment Partners fully exited Dominion Energy in Q4 2023, selling an estimated $9.76M.
  • Easterly Investment Partners's ten largest holdings make up 20% of its $935M portfolio in Q4 2023.
  • Easterly Investment Partners opened 24 new positions and closed 16 in Q4 2023.
  • Easterly Investment Partners's portfolio value rose 2.9% quarter-over-quarter to $935M.

Based on Easterly Investment Partners's 13F filing for Q4 2023, filed 14 Feb 2024.